Clinical Trial

Response to Aerobic Training in Postmenopausal Women With Exercise Intolerance.

Study acronym: WOMEN-EX-IC
Completed
View on ClinicalTrials.gov →
Summary
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide and represent a major public health challenge, with growing evidence highlighting important sex-related differences in their epidemiology, clinical presentation, and pathophysiology. In particular, menopause is associated with an increased cardiovascular risk, likely due to the decline in sex hormones and related changes in cardiac structure and function, vascular properties, and metabolic regulation. Several studies show that physical activity and, more specifically, aerobic training improves exercise tolerance and quality of life in patients. However, no studies have evaluated the effects of hormonal status, despite numerous studies on healthy subjects highlighting the influence of sex hormones on cardiovascular responses to acute and chronic exercise.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-12.
Trial Details
NCT Number NCT07422961
Lead Sponsor University of Poitiers
Collaborators: Elsan
Conditions Menopause, Physical Activity, Prevention, Cardiovascular (CV) Risk
Enrollment 43 participants
Start Date 2022-09-21
Primary Completion 2025-06-24 (estimated)
Study Completion 2025-07-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-27